Change Language
Cabita 500 mg Tablets

Cabita 500 mg Tablets

35 INR/Piece

Product Details:

  • Origin India
  • Salt Composition Capecitabine
  • Dosage Form Tablets
  • Indication Cancer treatment
  • Feature Other
  • Fermentation Smell Normal Smell
  • Storage Instructions Store below 30C
  • Click to view more
X

Cabita 500 mg Tablets Price And Quantity

  • 5000-1000 Piece
  • 35 INR/Piece

Cabita 500 mg Tablets Product Specifications

  • Other
  • India
  • Capecitabine
  • Store below 30C
  • Cancer treatment
  • 12 Months
  • Tablets
  • Normal Smell

Cabita 500 mg Tablets Trade Information

  • Cash in Advance (CID) Cash Advance (CA)
  • 10000 Piece Per Week
  • 15-20 Days
  • North America Eastern Europe Middle East Western Europe Central America South America Australia Africa Asia
  • All India

Product Description

A drug called capecitabine Tablets IP 500 mg is used in chemotherapy for cancer. The substance's main component, capecitabine, is an oral prodrug that the body uses to make 5-fluorouracil (5-FU). Antimetabolite 5-FU prevents cancer cells from synthesising DNA and RNA, hence limiting their ability to grow and divide.

For the treatment of many cancers, including as colorectal cancer, breast cancer, and gastric (stomach) cancer, capecitabine is frequently recommended. The oral tablets are normally prescribed by a medical professional with oncology experience.

Lowered blood cell counts, diarrhoea, hand-foot syndrome, and nausea are typical side effects of capecitabine. Based on each patient's medical condition and reaction to treatment, Capecitabine dosage and administration are tailored. Close medical supervision and monitoring are essential during treatment.

 

Features of 500 mg Capecitabine IP Tablets:

1. The active ingredient in the pills is capecitabine, an oral prodrug that the body transforms into the cancer treatment drug 5-fluorouracil (5-FU).

2. Cancer Treatment: Colorectal cancer, breast cancer, and gastric (stomach) cancer are among the list of cancers for which capecitabine Tablets IP 500 mg are specially prescribed.

3. The tablets are administered orally, offering a practical and non-intrusive means of drug delivery.

4. Antimetabolite Action: Capecitabine's conversion to 5-FU prevents cancer cells from synthesising DNA and RNA, hence limiting their ability to grow and divide.

5. Treatment Plan: The medicine is prescribed and dosed according to each patient's unique medical situation, offering a treatment plan that is particular to them.

 

Benefits of 500 mg Capecitabine Tablets:

1. Effective Cancer Management: Capecitabine has been shown to be effective in treating several cancers, including colorectal, breast, gastric, and other types of cancer, potentially providing advantages and bettering patient outcomes.

2. Reduced tumour size and suppression of cancer cell development are possible outcomes of the conversion of capecitabine to 5-FU.

3. Both curative and palliative uses of capecitabine are possible, with the drug providing symptom alleviation and better disease management for those with early-stage or metastatic malignancies.

4. Combination therapy: To improve overall cancer management, Capecitabine Tablets IP 500 mg may be administered in addition to other chemotherapy medications or therapies.

5. When opposed to intravenous chemotherapy, the oral administration of Capecitabine allows for easier compliance and administration.

6. Management of Resistant Cancers: Capecitabine can be utilised as a therapy option for individuals who have not responded to conventional therapies or who have experienced a relapse.

7. Less Serious Toxicity Profile: Capecitabine may have a less severe toxicity profile as compared to some other chemotherapy drugs, which enables many patients to tolerate it.

8. Convenience and Flexibility: Patients can take Capecitabine orally, which increases convenience and flexibility during therapy. This drug can be taken at home or in outpatient settings. 





FAQs of Cabita 500 mg Tablets:


Q: What is the recommended dosage for Cabita 500 mg Tablets?

A: The recommended dosage for Cabita 500 mg Tablets is 500mg.

Q: How should Cabita 500 mg Tablets be stored?

A: Cabita 500 mg Tablets should be stored at room temperature and below 30C.

Q: What is the physical form of Cabita 500 mg Tablets?

A: Cabita 500 mg Tablets are available in the form of tablets.

Q: What is the drug type of Cabita 500 mg Tablets?

A: Cabita 500 mg Tablets belong to the category of general medicines.

Q: What are the ingredients in Cabita 500 mg Tablets?

A: The ingredients in Cabita 500 mg Tablets include other components.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
+91
  • India (भारत)+91
  • United Arab Emirates (‫الإمارات العربية المتحدة‬‎)+971
  • United States+1
  • China (中国)+86
  • Afghanistan (‫افغانستان‬‎)+93
  • Albania (Shqipëri)+355
  • Algeria (‫الجزائر‬‎)+213
  • American Samoa+1684
  • Andorra+376
  • Angola+244
  • Anguilla+1264
  • Antigua and Barbuda+1268
  • Argentina+54
  • Armenia (Հայաստան)+374
  • Aruba+297
  • Australia+61
  • Austria (Österreich)+43
  • Azerbaijan (Azərbaycan)+994
  • Bahamas+1242
  • Bahrain (‫البحرين‬‎)+973
  • Bangladesh (বাংলাদেশ)+880
  • Barbados+1246
  • Belarus (Беларусь)+375
  • Belgium (België)+32
  • Belize+501
  • Benin (Bénin)+229
  • Bermuda+1441
  • Bhutan (འབྲུག)+975
  • Bolivia+591
  • Bosnia and Herzegovina (Босна и Херцеговина)+387
  • Botswana+267
  • Brazil (Brasil)+55
  • British Indian Ocean Territory+246
  • British Virgin Islands+1284
  • Brunei+673
  • Bulgaria (България)+359
  • Burkina Faso+226
  • Burundi (Uburundi)+257
  • Cambodia (កម្ពុជា)+855
  • Cameroon (Cameroun)+237
  • Canada+1
  • Cape Verde (Kabu Verdi)+238
  • Caribbean Netherlands+599
  • Cayman Islands+1345
  • Central African Republic (République centrafricaine)+236
  • Chad (Tchad)+235
  • Chile+56
  • China (中国)+86
  • Christmas Island+61
  • Cocos (Keeling) Islands+61
  • Colombia+57
  • Comoros (‫جزر القمر‬‎)+269
  • Congo (DRC) (Jamhuri ya Kidemokrasia ya Kongo)+243
  • Congo (Republic) (Congo-Brazzaville)+242
  • Cook Islands+682
  • Costa Rica+506
  • Côte d’Ivoire+225
  • Croatia (Hrvatska)+385
  • Cuba+53
  • Curaçao+599
  • Cyprus (Κύπρος)+357
  • Czech Republic (Česká republika)+420
  • Denmark (Danmark)+45
  • Djibouti+253
  • Dominica+1767
  • Dominican Republic (República Dominicana)+1
  • Ecuador+593
  • Egypt (‫مصر‬‎)+20
  • El Salvador+503
  • Equatorial Guinea (Guinea Ecuatorial)+240
  • Eritrea+291
  • Estonia (Eesti)+372
  • Ethiopia+251
  • Falkland Islands (Islas Malvinas)+500
  • Faroe Islands (Føroyar)+298
  • Fiji+679
  • Finland (Suomi)+358
  • France+33
  • French Guiana (Guyane française)+594
  • French Polynesia (Polynésie française)+689
  • Gabon+241
  • Gambia+220
  • Georgia (საქართველო)+995
  • Germany (Deutschland)+49
  • Ghana (Gaana)+233
  • Gibraltar+350
  • Greece (Ελλάδα)+30
  • Greenland (Kalaallit Nunaat)+299
  • Grenada+1473
  • Guadeloupe+590
  • Guam+1671
  • Guatemala+502
  • Guernsey+44
  • Guinea (Guinée)+224
  • Guinea-Bissau (Guiné Bissau)+245
  • Guyana+592
  • Haiti+509
  • Honduras+504
  • Hong Kong (香港)+852
  • Hungary (Magyarország)+36
  • Iceland (Ísland)+354
  • India (भारत)+91
  • Indonesia+62
  • Iran (‫ایران‬‎)+98
  • Iraq (‫العراق‬‎)+964
  • Ireland+353
  • Isle of Man+44
  • Israel (‫ישראל‬‎)+972
  • Italy (Italia)+39
  • Jamaica+1876
  • Japan (日本)+81
  • Jersey+44
  • Jordan (‫الأردن‬‎)+962
  • Kazakhstan (Казахстан)+7
  • Kenya+254
  • Kiribati+686
  • Kosovo+383
  • Kuwait (‫الكويت‬‎)+965
  • Kyrgyzstan (Кыргызстан)+996
  • Laos (ລາວ)+856
  • Latvia (Latvija)+371
  • Lebanon (‫لبنان‬‎)+961
  • Lesotho+266
  • Liberia+231
  • Libya (‫ليبيا‬‎)+218
  • Liechtenstein+423
  • Lithuania (Lietuva)+370
  • Luxembourg+352
  • Macau (澳門)+853
  • Macedonia (FYROM) (Македонија)+389
  • Madagascar (Madagasikara)+261
  • Malawi+265
  • Malaysia+60
  • Maldives+960
  • Mali+223
  • Malta+356
  • Marshall Islands+692
  • Martinique+596
  • Mauritania (‫موريتانيا‬‎)+222
  • Mauritius (Moris)+230
  • Mayotte+262
  • Mexico (México)+52
  • Micronesia+691
  • Moldova (Republica Moldova)+373
  • Monaco+377
  • Mongolia (Монгол)+976
  • Montenegro (Crna Gora)+382
  • Montserrat+1664
  • Morocco (‫المغرب‬‎)+212
  • Mozambique (Moçambique)+258
  • Myanmar (Burma) (မြန်မာ)+95
  • Namibia (Namibië)+264
  • Nauru+674
  • Nepal (नेपाल)+977
  • Netherlands (Nederland)+31
  • New Caledonia (Nouvelle-Calédonie)+687
  • New Zealand+64
  • Nicaragua+505
  • Niger (Nijar)+227
  • Nigeria+234
  • Niue+683
  • Norfolk Island+672
  • North Korea (조선 민주주의 인민 공화국)+850
  • Northern Mariana Islands+1670
  • Norway (Norge)+47
  • Oman (‫عُمان‬‎)+968
  • Pakistan (‫پاکستان‬‎)+92
  • Palau+680
  • Palestine (‫فلسطين‬‎)+970
  • Panama (Panamá)+507
  • Papua New Guinea+675
  • Paraguay+595
  • Peru (Perú)+51
  • Philippines+63
  • Poland (Polska)+48
  • Portugal+351
  • Puerto Rico+1
  • Qatar (‫قطر‬‎)+974
  • Réunion (La Réunion)+262
  • Romania (România)+40
  • Russia (Россия)+7
  • Rwanda+250
  • Saint Barthélemy+590
  • Saint Helena+290
  • Saint Kitts and Nevis+1869
  • Saint Lucia+1758
  • Saint Martin (Saint-Martin (partie française))+590
  • Saint Pierre and Miquelon (Saint-Pierre-et-Miquelon)+508
  • Saint Vincent and the Grenadines+1784
  • Samoa+685
  • San Marino+378
  • São Tomé and Príncipe (São Tomé e Príncipe)+239
  • Saudi Arabia (‫المملكة العربية السعودية‬‎)+966
  • Senegal (Sénégal)+221
  • Serbia (Србија)+381
  • Seychelles+248
  • Sierra Leone+232
  • Singapore+65
  • Sint Maarten+1721
  • Slovakia (Slovensko)+421
  • Slovenia (Slovenija)+386
  • Solomon Islands+677
  • Somalia (Soomaaliya)+252
  • South Africa+27
  • South Korea (대한민국)+82
  • South Sudan (‫جنوب السودان‬‎)+211
  • Spain (España)+34
  • Sri Lanka (ශ්‍රී ලංකාව)+94
  • Sudan (‫السودان‬‎)+249
  • Suriname+597
  • Svalbard and Jan Mayen+47
  • Swaziland+268
  • Sweden (Sverige)+46
  • Switzerland (Schweiz)+41
  • Syria (‫سوريا‬‎)+963
  • Taiwan (台灣)+886
  • Tajikistan+992
  • Tanzania+255
  • Thailand (ไทย)+66
  • Timor-Leste+670
  • Togo+228
  • Tokelau+690
  • Tonga+676
  • Trinidad and Tobago+1868
  • Tunisia (‫تونس‬‎)+216
  • Turkey (Türkiye)+90
  • Turkmenistan+993
  • Turks and Caicos Islands+1649
  • Tuvalu+688
  • U.S. Virgin Islands+1340
  • Uganda+256
  • Ukraine (Україна)+380
  • United Arab Emirates (‫الإمارات العربية المتحدة‬‎)+971
  • United Kingdom+44
  • United States+1
  • Uruguay+598
  • Uzbekistan (Oʻzbekiston)+998
  • Vanuatu+678
  • Vatican City (Città del Vaticano)+39
  • Venezuela+58
  • Vietnam (Việt Nam)+84
  • Wallis and Futuna (Wallis-et-Futuna)+681
  • Western Sahara (‫الصحراء الغربية‬‎)+212
  • Yemen (‫اليمن‬‎)+967
  • Zambia+260
  • Zimbabwe+263
  • Åland Islands+358
Mobile number

Email

Other Products in 'Anti Cancer Medicines & Injections' category



"We mainly deliver our products to the foreign countries."
Back to top